Evidence map›Paper›PMID 26083036›Full record

ArticleMolecules (Basel, Switzerland)2015

In Vivo Nanodetoxication for Acute Uranium Exposure.

Luis Guzmán, Esteban F Durán-Lara, Wendy Donoso, Fabiane M Nachtigall, Leonardo S Santos

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Luis GuzmánLaboratory of Asymmetric Synthesis, Institute of Chemistry and Natural Resources, University of Talca, P.O. Box 747, Talca 3460000, Maule, Chile. fmanke@utalca.cl.
Esteban F Durán-LaraLaboratory of Asymmetric Synthesis, Institute of Chemistry and Natural Resources, University of Talca, P.O. Box 747, Talca 3460000, Maule, Chile. fmanke@utalca.cl.
Wendy DonosoLaboratory of Asymmetric Synthesis, Institute of Chemistry and Natural Resources, University of Talca, P.O. Box 747, Talca 3460000, Maule, Chile. wdonoso@utalca.cl.
Fabiane M NachtigallNanobiotechnology Division at Talca University, Fraunhofer Chile Research Foundation-Center for Systems Biotechnology, FCR-CSB, P.O. Box 747, Talca 3460000, Maule, Chile. fmanke@utalca.cl.
Leonardo S SantosLaboratory of Asymmetric Synthesis, Institute of Chemistry and Natural Resources, University of Talca, P.O. Box 747, Talca 3460000, Maule, Chile. lssantos@utalca.cl.
University of Talca · CLFraunhofer Chile Research Foundation · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accidental exposure to uranium is a matter of concern, as U(VI) is nephrotoxic in both human and animal models, and its toxicity is associated to chemical toxicity instead of radioactivity. We synthesized different PAMAM G4 and G5 derivatives in order to prove their interaction with uranium and their effect on the viability of red blood cells in vitro. Furthermore, we prove the effectiveness of the selected dendrimers in an animal model of acute uranium intoxication. The dendrimer PAMAM G4-Lys-Fmoc-Cbz demonstrated the ability to chelate the uranyl ion in vivo, improving the biochemical and histopathologic features caused by acute intoxication with uranium.

Indexed as

NanoparticlesAcute Radiation SyndromeAnimalsBiomarkersChelating AgentsDendrimersDisease Models, AnimalErythrocytesHemolysisHumansKidneyMaleMiceNylonsRadiation ExposureUraniumBiomarkersChelating AgentsDendrimersNylonsPAMAM-G4Uraniumacute intoxicationchelating agentPAMAM dendrimer derivativesuranium

Identifiers

PMID26083036
PMCPMC6272616
OpenAlexW1572766219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.